Skip to main navigation
  • Investors
Alnylam

John M. Maraganore Ph.D.

    Recent Press Releases

    View all releases  RSS

    • Mar 30,2026
      Summary ToggleNew Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management
    • Mar 24,2026
      Summary ToggleAlnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association
    • Mar 10,2026
      Summary ToggleAlnylam to Webcast TTR Investor Webinar
    View all releases

    : (Common):

    Price:
    Change (%):
    Volume:
    Data as of
    Copyright Refinitiv. Minimum 15 minutes delay
    Learn More
    • X
    • linkedin
    • youtube

    Copyright © 2026 Alnylam Pharmaceuticals, Inc.   ---   All Rights Reserved   ---   Media Kit   |   Legal Notice   |   Privacy Policy   |   Site Map